DiaMedica Therapeutics (DMAC) Net Equity Issued and Repurchased (2020 - 2025)
DiaMedica Therapeutics (DMAC) posted quarterly Net Equity Issued and Repurchased of $11.8 million for Q4 2025, down 62.71% quarter-over-quarter from $31.5 million in Q3 2025.
DiaMedica Therapeutics (DMAC) Net Equity Issued and Repurchased (2020 - 2025) Analysis & Trends
DiaMedica Therapeutics' Net Equity Issued and Repurchased history runs 4 years deep, the most recent figure standing at $11.8 million for Q4 2025.
- In Q4 2025, Net Equity Issued and Repurchased changed N/A year-over-year to $11.8 million; the TTM figure through Dec 2025 stood at $43.3 million (up 1082150.0% YoY), while the FY2025 annual figure was $43.3 million, up 268.45% from the prior year.
- Net Equity Issued and Repurchased for Q4 2025 stood at $11.8 million, down from $31.5 million in the prior quarter.
- The five-year high for Net Equity Issued and Repurchased was $31.5 million in Q3 2025, with the low at -$18000.0 in Q4 2021.
- The 3-year median for Net Equity Issued and Repurchased is $11.8 million (2025), against an average of $14.6 million.
- Peak annual rise in Net Equity Issued and Repurchased reached 73.13% in 2021, while the deepest fall reached 40.95% in 2021.
- DiaMedica Therapeutics' Net Equity Issued and Repurchased stood at -$18000.0 in 2021, then jumped by 77.78% to -$4000.0 in 2023, then soared by 293975.0% to $11.8 million in 2025.
- Business Quant data shows DMAC's Net Equity Issued and Repurchased at $11.8 million in Q4 2025, $31.5 million in Q3 2025, and -$4000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 141.90 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | DiaMedica Therapeutics | 360.22 Mn | 360.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.76 Mn |
| Dec 31, 2025 | 11.76 Mn |
| Sep 30, 2025 | 31.53 Mn |
| Sep 30, 2025 | 31.53 Mn |
| Sep 30, 2023 | -4,000.00 |
| Sep 30, 2023 | -4,000.00 |
| Dec 31, 2021 | -18,000.00 |
| Dec 31, 2021 | -18,000.00 |
| Sep 30, 2021 | 29.87 Mn |
| Sep 30, 2021 | 29.87 Mn |
| Dec 31, 2020 | -67,000.00 |
| Dec 31, 2020 | -67,000.00 |
| Sep 30, 2020 | 21.19 Mn |
| Sep 30, 2020 | 21.19 Mn |
| Mar 31, 2020 | 7.68 Mn |
| Mar 31, 2020 | 7.68 Mn |